The expression levels of TFAP2A and TFAP2C are reduced post-translationally during TNFα-induced cell apoptosis, during which TFAP2A is cleaved by caspase 6 and degraded by the proteasome in the breast cancer cells [170]. The gene discussed is TFAP2C; the disease is breast carcinoma.